Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Renal Transplantation Followed By Infusion of T-Regulatory Cells Made With Belatacept Ex-Vivo

NCT02091232 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02091232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02091232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Renal Transplantation Followed By Infusion of T-Regulatory Cells Made With Belatacept Ex-Vivo
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2014
Completion date
March 2, 2016
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney failure, kidney transplant